VCM
NVNO

Vanguard Capital Management’s enVVeno Medical NVNO Stock Holding History

Vanguard Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.7K Buy
+6,287
New +$68.8K ﹤0.01% 3893

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Capital Management's NVNO Position: Q1 2026 in Review

Vanguard Capital Management opened a new position in enVVeno Medical (NVNO) in Q1 2026: 6,287 shares worth $63.7K. The stake represents ﹤0.01% of the portfolio and ranks #3893 among its holdings.

17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Vanguard Capital Management held 6,287 shares of enVVeno Medical worth $63.7K as of Q1 2026.
  • enVVeno Medical was a new Vanguard Capital Management position in Q1 2026.
  • enVVeno Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q1 2026, its #3893 holding.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.